 |
PDBsum entry 2dyh
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
2dyh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Mol Cell Biol
27:7511-7521
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response.
|
|
K.I.Tong,
B.Padmanabhan,
A.Kobayashi,
C.Shang,
Y.Hirotsu,
S.Yokoyama,
M.Yamamoto.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Nrf2 is the regulator of the oxidative/electrophilic stress response. Its
turnover is maintained by Keap1-mediated proteasomal degradation via a two-site
substrate recognition mechanism in which two Nrf2-Keap1 binding sites form a
hinge and latch. The E3 ligase adaptor Keap1 recognizes Nrf2 through its
conserved ETGE and DLG motifs. In this study, we examined how the ETGE and DLG
motifs bind to Keap1 in a very similar fashion but with different binding
affinities by comparing the crystal complex of a Keap1-DC domain-DLG peptide
with that of a Keap1-DC domain-ETGE peptide. We found that these two motifs
interact with the same basic surface of either Keap1-DC domain of the Keap1
homodimer. The DLG motif works to correctly position the lysines within the Nrf2
Neh2 domain for efficient ubiquitination. Together with the results from
calorimetric and functional studies, we conclude that different electrostatic
potentials primarily define the ETGE and DLG motifs as a hinge and latch that
senses the oxidative/electrophilic stress.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.M.Boyden,
M.Choi,
K.A.Choate,
C.J.Nelson-Williams,
A.Farhi,
H.R.Toka,
I.R.Tikhonova,
R.Bjornson,
S.M.Mane,
G.Colussi,
M.Lebel,
R.D.Gordon,
B.A.Semmekrot,
A.Poujol,
M.J.Välimäki,
M.E.De Ferrari,
S.A.Sanjad,
M.Gutkin,
F.E.Karet,
J.R.Tucci,
J.R.Stockigt,
K.M.Keppler-Noreuil,
C.C.Porter,
S.K.Anand,
M.L.Whiteford,
I.D.Davis,
S.B.Dewar,
A.Bettinelli,
J.J.Fadrowski,
C.W.Belsha,
T.E.Hunley,
R.D.Nelson,
H.Trachtman,
T.R.Cole,
M.Pinsk,
D.Bockenhauer,
M.Shenoy,
P.Vaidyanathan,
J.W.Foreman,
M.Rasoulpour,
F.Thameem,
H.Z.Al-Shahrouri,
J.Radhakrishnan,
A.G.Gharavi,
B.Goilav,
and
R.P.Lifton
(2012).
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
|
| |
Nature,
482,
98.
|
 |
|
|
|
|
 |
L.Baird,
and
A.T.Dinkova-Kostova
(2011).
The cytoprotective role of the Keap1-Nrf2 pathway.
|
| |
Arch Toxicol,
85,
241-272.
|
 |
|
|
|
|
 |
G.P.Sykiotis,
and
D.Bohmann
(2010).
Stress-activated cap'n'collar transcription factors in aging and human disease.
|
| |
Sci Signal,
3,
re3.
|
 |
|
|
|
|
 |
J.Shlomai
(2010).
Redox control of protein-DNA interactions: from molecular mechanisms to significance in signal transduction, gene expression, and DNA replication.
|
| |
Antioxid Redox Signal,
13,
1429-1476.
|
 |
|
|
|
|
 |
M.Komatsu,
H.Kurokawa,
S.Waguri,
K.Taguchi,
A.Kobayashi,
Y.Ichimura,
Y.S.Sou,
I.Ueno,
A.Sakamoto,
K.I.Tong,
M.Kim,
Y.Nishito,
S.Iemura,
T.Natsume,
T.Ueno,
E.Kominami,
H.Motohashi,
K.Tanaka,
and
M.Yamamoto
(2010).
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1.
|
| |
Nat Cell Biol,
12,
213-223.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.C.Siow,
and
G.E.Mann
(2010).
Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis?
|
| |
Mol Aspects Med,
31,
468-477.
|
 |
|
|
|
|
 |
R.Hu,
C.L.Saw,
R.Yu,
and
A.N.Kong
(2010).
Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.
|
| |
Antioxid Redox Signal,
13,
1679-1698.
|
 |
|
|
|
|
 |
T.Ogura,
K.I.Tong,
K.Mio,
Y.Maruyama,
H.Kurokawa,
C.Sato,
and
M.Yamamoto
(2010).
Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains.
|
| |
Proc Natl Acad Sci U S A,
107,
2842-2847.
|
 |
|
|
|
|
 |
V.Calabrese,
C.Cornelius,
A.T.Dinkova-Kostova,
E.J.Calabrese,
and
M.P.Mattson
(2010).
Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.
|
| |
Antioxid Redox Signal,
13,
1763-1811.
|
 |
|
|
|
|
 |
Y.Nakamura,
and
N.Miyoshi
(2010).
Electrophiles in foods: the current status of isothiocyanates and their chemical biology.
|
| |
Biosci Biotechnol Biochem,
74,
242-255.
|
 |
|
|
|
|
 |
A.L.Eggler,
E.Small,
M.Hannink,
and
A.D.Mesecar
(2009).
Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1.
|
| |
Biochem J,
422,
171-180.
|
 |
|
|
|
|
 |
E.Kansanen,
A.M.Kivelä,
and
A.L.Levonen
(2009).
Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2.
|
| |
Free Radic Biol Med,
47,
1310-1317.
|
 |
|
|
|
|
 |
F.Zhao,
T.Wu,
A.Lau,
T.Jiang,
Z.Huang,
X.J.Wang,
W.Chen,
P.K.Wong,
and
D.D.Zhang
(2009).
Nrf2 promotes neuronal cell differentiation.
|
| |
Free Radic Biol Med,
47,
867-879.
|
 |
|
|
|
|
 |
G.S.Shim,
S.Manandhar,
D.H.Shin,
T.H.Kim,
and
M.K.Kwak
(2009).
Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway.
|
| |
Free Radic Biol Med,
47,
1619-1631.
|
 |
|
|
|
|
 |
J.Clark,
and
D.K.Simon
(2009).
Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease.
|
| |
Antioxid Redox Signal,
11,
509-528.
|
 |
|
|
|
|
 |
J.D.Hayes,
and
M.McMahon
(2009).
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.
|
| |
Trends Biochem Sci,
34,
176-188.
|
 |
|
|
|
|
 |
L.Gao,
and
G.E.Mann
(2009).
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
|
| |
Cardiovasc Res,
82,
9.
|
 |
|
|
|
|
 |
M.Zhuang,
M.F.Calabrese,
J.Liu,
M.B.Waddell,
A.Nourse,
M.Hammel,
D.J.Miller,
H.Walden,
D.M.Duda,
S.N.Seyedin,
T.Hoggard,
J.W.Harper,
K.P.White,
and
B.A.Schulman
(2009).
Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases.
|
| |
Mol Cell,
36,
39-50.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Holland,
M.Navamal,
M.Velayutham,
J.L.Zweier,
T.W.Kensler,
and
J.C.Fishbein
(2009).
Hydrogen peroxide is a second messenger in phase 2 enzyme induction by cancer chemopreventive dithiolethiones.
|
| |
Chem Res Toxicol,
22,
1427-1434.
|
 |
|
|
|
|
 |
W.Chen,
Z.Sun,
X.J.Wang,
T.Jiang,
Z.Huang,
D.Fang,
and
D.D.Zhang
(2009).
Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response.
|
| |
Mol Cell,
34,
663-673.
|
 |
|
|
|
|
 |
W.Li,
and
A.N.Kong
(2009).
Molecular mechanisms of Nrf2-mediated antioxidant response.
|
| |
Mol Carcinog,
48,
91.
|
 |
|
|
|
|
 |
Z.Sun,
Y.E.Chin,
and
D.D.Zhang
(2009).
Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response.
|
| |
Mol Cell Biol,
29,
2658-2672.
|
 |
|
|
|
|
 |
Z.Sun,
Z.Huang,
and
D.D.Zhang
(2009).
Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response.
|
| |
PLoS One,
4,
e6588.
|
 |
|
|
|
|
 |
B.Padmanabhan,
K.I.Tong,
A.Kobayashi,
M.Yamamoto,
and
S.Yokoyama
(2008).
Structural insights into the similar modes of Nrf2 transcription factor recognition by the cytoplasmic repressor Keap1.
|
| |
J Synchrotron Radiat,
15,
273-276.
|
 |
|
|
|
|
 |
B.Padmanabhan,
Y.Nakamura,
and
S.Yokoyama
(2008).
Structural analysis of the complex of Keap1 with a prothymosin alpha peptide.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
64,
233-238.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Mamiya,
F.Katsuoka,
A.Hirayama,
O.Nakajima,
A.Kobayashi,
J.M.Maher,
H.Matsui,
I.Hyodo,
M.Yamamoto,
and
T.Hosoya
(2008).
Hepatocyte-specific deletion of heme oxygenase-1 disrupts redox homeostasis in basal and oxidative environments.
|
| |
Tohoku J Exp Med,
216,
331-339.
|
 |
|
|
|
|
 |
T.Shibata,
T.Ohta,
K.I.Tong,
A.Kokubu,
R.Odogawa,
K.Tsuta,
H.Asamura,
M.Yamamoto,
and
S.Hirohashi
(2008).
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.
|
| |
Proc Natl Acad Sci U S A,
105,
13568-13573.
|
 |
|
|
|
|
 |
T.Yamamoto,
T.Suzuki,
A.Kobayashi,
J.Wakabayashi,
J.Maher,
H.Motohashi,
and
M.Yamamoto
(2008).
Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity.
|
| |
Mol Cell Biol,
28,
2758-2770.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |